IQCP 30-Day QC: Extending External QC to Monthly

Yes, an IQCP can set external liquid QC at every 30 days, but only when your own in-house data covers at least that 30-day interval, the risk assessment supports it, the test system has adequate internal controls, the laboratory director signs the plan, and the manufacturer doesn't require QC more often.

Under default CLIA QC, most quantitative nonwaived tests need two levels of control each day of testing (42 CFR 493.1256). An IQCP is the only CMS-approved route to a different frequency. This page explains what has to be true before a 30-day interval is defensible.

Last reviewed Oct 2026 · By Sound Lab Consultants CLIA team · General information, not legal advice.

Book a free consultation

Where the 30-day figure comes from

The 30-day number isn't a CLIA rule. It shows up in two places:

The Developing an IQCP - A Step-By-Step Guide (CDC/CMS workbook) uses an example test system whose package insert recommends external controls at least every 30 days. The example lab's QC plan runs normal and abnormal external QC every 30 days or on the first day of patient testing each month, plus at each new reagent lot and at other trigger events.
the CAP's public IQCP FAQ (updated Nov 2024) uses 30 days as its example: if a lab wants external QC every 30 days, the in-house study must span at least 30 days. CAP also says it removed an older checklist statement that required external QC at least every 31 days under an IQCP.

So the interval is the lab's choice, made by the laboratory director and backed by data. 30 days is a common example, not a ceiling or a default.

What the supporting data must show

CMS says in-house data, collected in your own environment by your own personnel, must show that the test system's stability supports the number and frequency of QC in the plan. CMS isn't prescriptive about how much data that takes; the laboratory director decides (CMS IQCP Frequently Asked Questions (Aug 2016)). The CAP FAQ adds:

The study period has to cover at least the maximum interval you choose between external QC runs.
Consecutive days aren't specifically required when testing is sporadic or not done seven days a week.
Historical data for tests already in place can be used, and published literature can supplement it.
For a new test, the CAP describes starting with a shorter interval (for example, a seven-day study and weekly QC) and extending it only after more data is gathered and the director approves the updated IQCP.

Data commonly pulled into the study includes daily QC results run under default QC, internal control records, proficiency testing results, verification studies, maintenance and function-check logs, and corrective action records.

What external QC still has to happen

New lots and shipments: the CAP requires external QC with each new lot and shipment of reagents in an IQCP's quality control plan.
Manufacturer triggers: the CDC/CMS workbook example also runs external QC when lab conditions change significantly, when staff are trained or retrained, and when results don't match the patient's clinical picture.
Never below the manufacturer: CMS, CDC and the CAP all say the QC plan can't be less stringent than the manufacturer's instructions.

Internal and procedural controls

Extended external QC only makes sense when something else watches the test between external runs. CMS describes IQCP as recognizing electronic, internal and procedural controls built into test systems. The CAP limits most IQCP eligibility to test systems with an internal control process (electronic, procedural or built-in), with exceptions in microbiology. Your risk assessment has to show which errors those internal controls actually catch. The CAP notes that function checks and electronic checks may monitor only part of the analytic process.

How the three IQCP parts fit a 30-day plan

Risk assessment: evaluate specimen, test system, reagent, environment and testing personnel risks across all phases of testing, and document which control catches each one. See IQCP risk assessment.
Quality control plan: state the number, type and frequency of controls, the acceptance criteria and the trigger events. The laboratory director signs and dates it, and CMS says that approval can't be delegated.
Quality assessment: monitor QC failures, errors, PT results and complaints to confirm the 30-day interval is still working. See IQCP quality assessment and review.

When to tighten or revert

Go back to a shorter interval, or to default QC, when quality assessment shows the plan isn't working. Typical signals are QC or internal-control failures, PT problems, clinician complaints, or a change in reagents, staff, location or the test system. CMS notes that surveyors don't usually cite a director's risk decisions directly. They find the downstream problems in QC, QA and PT and cite those.

For a point-of-care angle, Westgard's outside review of a point-of-care IQCP shows how a sample POC IQCP built mostly from manufacturer documents missed environment, personnel and multiple-device risks. That kind of gap makes a long QC interval harder to defend.

IQCP 30-Day QC checklist

☐ Confirm the test is nonwaived and eligible (not pathology; CAP labs also check CAP's internal-control rule)
☐ Pull the manufacturer's QC frequency and make sure 30 days isn't shorter than it allows
☐ Gather in-house QC and internal-control data spanning at least 30 days
☐ Add PT, verification, maintenance and corrective-action records
☐ Document which internal or procedural control catches each identified risk
☐ Write the QC plan: number, type, frequency, acceptance criteria, new lot/shipment and trigger events
☐ Get laboratory director signature and date before use
☐ Set quality assessment monitors and a review schedule
☐ Define the triggers for returning to a shorter interval

CDC resources on CLIA

CDC's overview of the CLIA program: CDC explains that CLIA applies to every U.S. site that tests human specimens to assess health or to diagnose, prevent, or treat disease. It also explains that CDC supports the program alongside CMS and FDA.
CDC on CLIA test complexity categories: CDC explains how FDA scores tests as moderate or high complexity using seven criteria. It also notes that lab-developed or modified tests default to high complexity, and that moderate and high complexity standards differ only in personnel requirements.
CDC's free CLIA educational materials: CDC offers brochures and booklets on waived testing, PPM, and IQCP.

Frequently asked questions

Can IQCP extend QC to once every 30 days?

Yes, if your in-house data spans at least 30 days and supports the interval, the risk assessment backs it, the manufacturer doesn't require more frequent QC, and the laboratory director approves the plan.

How many days of data do I need for an IQCP?

CMS doesn't set a number; the laboratory director decides. The CAP says the study must cover at least the maximum interval between external QC runs, so a 30-day interval needs at least 30 days of data.

Do the 30 days of QC have to be consecutive?

The CAP says consecutive days aren't specifically required if testing is sporadic or not done seven days a week.

Can an IQCP be less stringent than the manufacturer's instructions?

No. CMS, CDC and the CAP all say the QC plan can't be less stringent than the manufacturer's instructions.

Do I still run external QC on new reagent lots?

Yes. The CAP requires external QC with each new lot and shipment in an IQCP's quality control plan, and manufacturers often list other trigger events.

Is 31-day external QC still required by the CAP under IQCP?

No. The CAP says it removed that statement in 2017. The data still has to cover the maximum interval you choose.

When should a lab go back to daily QC?

When quality assessment shows QC failures, errors, PT problems or complaints suggest the plan isn't controlling risk, or when the test system, reagents, staff or location change.

Official sources and further reading

Related IQCP guides

Talk to an IQCP consultant

Sound Lab Consultants helps labs nationwide build, review and maintain IQCPs from their own data and the official CMS and CDC guidance.

Sound Lab Consultants, PO Box 2135, Chandler, AZ 85244

Book a free consultation